NAMS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -1.058, suggesting NAMS is Strong Sell.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 32.242, while NewAmsterdam Pharma Company NV (NAMS) share price is $29.83, making it Sell.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 32.819, while NewAmsterdam Pharma Company NV (NAMS) share price is $29.83, making it Sell.

Technical Analysis for NAMS

Technical Sentiment Analysis for NewAmsterdam Pharma Company NV (NAMS) As of 2026-06-18, NewAmsterdam Pharma Company NV (NAMS) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 11 technical signals, shows that 2 indicators are flashing buy, while 9 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for NAMS stands at 38.334, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -1.058, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 15.409 and the Commodity Channel Index (CCI) at -74.282 further confirm a -2.84 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, NAMS is trading below its 60-day moving average of $32.819 and below its 200-day long-term moving average of $33.281. Key price levels to watch include the immediate resistance at $32.716 and strong support at $28.551. A break above $32.716 could signal a bull continuation, while falling below $28.551 may test the next Fibonacci floor at $26.74.

NewAmsterdam Pharma Company NV (NAMS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	24.386	26.74	28.551	30.905	32.716	35.07	36.881
Fibonacci	26.74	28.331	29.314	30.905	32.496	33.479	35.07

NewAmsterdam Pharma Company NV (NAMS) Technical Indicators

2026-06-18

Name	Value
RSI_14	38.334
STOCHk_14_3_3	15.409
STOCHd_14_3_3	15.676
CCI_20	-74.282
AO_5_34	-2.759
MOM_10	-2.84
MACD_12_26_9	-1.058

NewAmsterdam Pharma Company NV (NAMS) Relative Strength Index (RSI) is 38.334, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic Oscillator is 15.409, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic RSI is 15.676, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Commodity Channel Index (CCI) is -74.282, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Awesome Oscillator is -2.759, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) Momentum is -2.84, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) MACD is -1.058, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) Moving Average

2026-06-18

Period	Simple	Signal
MA_5	30.234	Sell
MA_10	30.361	Sell
MA_20	32.242	Sell
MA_60	32.819	Sell
MA_200	33.281	Sell
MA_250	31.103	Sell

NewAmsterdam Pharma Company NV (NAMS) 5-Day simple moving average is 30.234, while NewAmsterdam Pharma Company NV (NAMS) share price is $29.83, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 10-Day simple moving average is 30.361, while NewAmsterdam Pharma Company NV (NAMS) share price is $29.83, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 32.242, while NewAmsterdam Pharma Company NV (NAMS) share price is $29.83, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 32.819, while NewAmsterdam Pharma Company NV (NAMS) share price is $29.83, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 200-Day simple moving average is 33.281, while NewAmsterdam Pharma Company NV (NAMS) share price is $29.83, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 250-Day simple moving average is 31.103, while NewAmsterdam Pharma Company NV (NAMS) share price is $29.83, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for NAMS?

The overall technical consensus for NewAmsterdam Pharma Company NV (NAMS) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 2 buy signals and 3 sell signals.

What are the key support and resistance levels for NewAmsterdam Pharma Company NV (NAMS) today?

Based on pivot point calculations, NewAmsterdam Pharma Company NV (NAMS) has an immediate support level at 28.551 and a major resistance level at 32.716. Traders also monitor the pivot point at 30.905 to determine the intraday trend direction.

Is NewAmsterdam Pharma Company NV (NAMS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for NewAmsterdam Pharma Company NV (NAMS) is currently 38.334. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for NewAmsterdam Pharma Company NV (NAMS)?

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -1.058, suggesting NAMS is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for NewAmsterdam Pharma Company NV.

How is NewAmsterdam Pharma Company NV (NAMS) performing relative to its 200-day moving average?

NewAmsterdam Pharma Company NV (NAMS) is currently trading at $29.83, which is below its 200-day simple moving average of 33.281. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.